Art Levinson (Calico)

Google-backed Cal­i­co dou­bles down on an­ti-ag­ing R&D pact with Ab­b­Vie as part­ners ante up $1B, start to de­tail drug tar­gets

Sev­en years af­ter strik­ing up a ma­jor R&D al­liance, Ab­b­Vie and Google-backed an­ti-ag­ing spe­cial­ist Cal­i­co are dou­bling down on their work with a joint, $1 bil­lion com­mit­ment to con­tin­u­ing their work to­geth­er. And they’re al­so be­gin­ning to of­fer some de­tails on where this project is tak­ing them in the clin­ic.

Ac­cord­ing to their state­ment, each of the two play­ers is putting up $500 mil­lion more to keep the labs hum­ming.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.